Replies to post #48590 on PharmaCyte Biotech Inc (PMCB)

[Runuvi]

Au contraire, why would TD2 with the worlds leading oncologist at the helm, design a clinical trial that if fundamentally impossible to execute. Pretty far fetched.

[Peacefulwendy]

I think Dr Von Hoff and TD2 have more knowledge about the availability of patients for this trial than anyone here. So, I will continue to trust that the doctors know what they are doing.

And where are you getting your information? And why would you refer to these patients as leftovers?

None of my DD says that they can't go head to head. I can see many reasons that they would choose not to go head to head. And a big reason is Dr Von Hoff. He is a CELG consultant. He is working with all involved to get this treatment to patients and we must not forget he contacted us...